CD57+ EMRA CD8+ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy

These findings underscore the impact of prior chemotherapy on expanding the pool of senescent T cells, particularly CD57<sup>+</sup> EMRA CD8<sup>+</sup> T and CD57<sup>+</sup> GRZB<sup>+</sup> EMRA CD8<sup>+</sup> T cells, whose expansion could potentially affect the effectiveness of anti-PD-1/PD-L1 immunotherapy in elderly patients. This highlights the need for tailored approaches in this population.

Authors

Institutions

Publication Details

Journal
Immunity & Ageing
Published
2024-12-27
DOI
https://doi.org/10.1186/s12979-024-00487-4
Citations
4
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD57+ EMRA CD8+ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy

Pierre-André Natella, Éléna Paillaud, Axelle Histe, Pascaline Boudou‐Rouquette et al.
4 citations
Immunity & Ageing
Cancer Immunotherapy and Biomarkers
1.13
article

CD57+ EMRA CD8+ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy

Pierre-André Natella, Éléna Paillaud, Axelle Histe, Pascaline Boudou‐Rouquette, Johanna Canovas, Éric Tartour, Anis Larbi, Florence Canouï‐Poitrine, Clémence Granier, Philippe Caillet, Richard Layese, Cécile Gonnin, Johanne Poisson, Besma Saadaoui, Michelle Leemans, Aurélien Corneau, Hélène Vallet, Pauline Ober, Morgane Lebraud, Catherine Blanc, Pierre Gay, Carine El-Sissy, Louise Roquebert
article en
4 citations

Abstract

These findings underscore the impact of prior chemotherapy on expanding the pool of senescent T cells, particularly CD57<sup>+</sup> EMRA CD8<sup>+</sup> T and CD57<sup>+</sup> GRZB<sup>+</sup> EMRA CD8<sup>+</sup> T cells, whose expansion could potentially affect the effectiveness of anti-PD-1/PD-L1 immunotherapy in elderly patients. This highlights the need for tailored approaches in this population.

Immunity & AgeingVol. 21(1)
Université de Sherbrooke (CA), Inserm (FR), Université Paris-Est Créteil (FR), Université Paris Cité (FR), Sorbonne Université (FR), Sorbonne Paris Cité (FR), Centre de Recherche des Cordeliers (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Européen Georges-Pompidou (FR), Hôpital Saint-Antoine (FR), Hôpital Européen (FR), Centre d'Immunologie et des Maladies Infectieuses (FR), Centre de Recherche sur l'Inflammation (FR), Hôpitaux Universitaires Henri-Mondor (FR), Paris Cardiovascular Research Center (FR), Laboratoire d’immunologie intégrative du cancer (FR), Centre de Recherche Saint-Antoine (FR), Institut Mondor de Recherche Biomédicale (FR)
Good health and well-being
Openalex Percentile: Top 17%
Cancer Immunotherapy and Biomarkers
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.